JACC Global
by American College of Cardiology
Latest episode
ICI Myocarditis: Does Timing Define the Disease? | JACC Baran
ICI Myocarditis: Does Timing Define the Disease? | JACC Baran
About this podcast
Explore cardiovascular science from a global perspective with JACC Global. This podcast highlights original research, regional innovations, and urgent challenges in heart health across diverse healthcare settings worldwide.
Episodes
The newest 20 of 93 episodes
- ICI Myocarditis: Does Timing Define the Disease? | JACC Baran · 34 minIs immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and…
- ICI Myocarditis: Does Timing Define the Disease? | JACC Baran · 34 minIs immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and…
- Does PFA Reach the Vein of Marshall? | JACC Baran · 36 minDoes pulsed field ablation (PFA) for pulmonary vein isolation affect structures beyond the pulmonary veins? Host Mitsuaki Sawano, MD, welcomes Yosuke Nakatani, MD (Gunma…
- A SELUTION to Paclitaxel DCB Complications in PAD? | JACC Baran · 28 minCould sirolimus-coated balloons change how we treat femoropopliteal peripheral artery disease? Host Mitsuaki Sawano, MD, welcomes Yoshimitsu Soga, MD, PhD (Kokura Memorial…
- Proteomics in Action: Finding the Right Drug Targets for Ischemic Heart Disease | JACC Baran · 36 minWhich of the thousands of biomarkers associated with cardiovascular disease could actually become a useful drug target? Host Mitsuaki Sawano, MD, and co-host Nobuhiro Ikemura…
- PET Unmasks CMD: The Hidden Risk Behind Normal Perfusion | JACC Baran · 37 minHosts Mitsuaki Sawano, MD, Satoshi Shoji, MD, and Kentaro Ejiri, MD, welcome Yoshito Kadoya, MD, PhD (University of British Columbia / St. Paul’s Hospital) to discuss his JACC…
- Rethinking Health Care at Home and Abroad: Lancet RH Western Pacific Special | JACC Baran · 40 minHost Mitsuaki Sawano, MD, welcomes Shuhei Nomura, PhD (Tohoku University), Lisa Yamasaki, MD (Harvard T.H. Chan School of Public Health), and Haruka Sakamoto, MD, PhD (St. Luke’s…
- PFA Changes the Game and the AT Circuit | JACC Baran · 37 minHosts Mitsuaki Sawano, MD, and Hiroyuki Sato, MD, welcome Kazutaka Nakasone, MD (Kobe University) to discuss his JACC: Clinical Electrophysiology study on atrial tachycardia (AT)…
- Is “Normal” Hemoglobin Really Normal in Heart Failure? | JACC Baran · 33 minHosts Mitsuaki Sawano, MD, and Satoshi Shoji, MD, welcome Misato Chimura, MD, PhD (University of Glasgow) to discuss her ESC SimPub paper in JACC, “Low-normal hemoglobin…
- BRIDGING the Lipid Management Gap After ACS: ESC Late-Breaker | JACC Baran · 43 minHosts Mitsuaki Sawano, MD, and Shun Kohsaka, MD, welcome Kazuma Ohyama, MD, PhD (Tohoku University) to discuss the BRIDGE trial, Protocol-Based Implementation of Early Intensive…
- ESC 2026 Special: JACC SimPub Papers You Should Know | JACC Baran · 36 minHosts Mitsuaki Sawano, MD, Takeshi Kitai, MD, PhD, Kentaro Ejiri, MD, PhD, and Satoshi Shoji, MD, PhD, highlight three JACC papers presented at ESC 2026 and simultaneously…
- The Lancet: OPTIMA-AF, Is 1 Month Enough After PCI? | JACC Baran · 48 minHosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD, welcome Yohei Sotomi, MD, PhD (The University of Osaka), and Ken Kozuma, MD, PhD (Teikyo…
- HFpEF: Why Earlier May Be Better | JACC Baran · 38 minHosts Mitsuaki Sawano, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD welcome Shunichi Doi, MD (St. Marianna University School of Medicine) to discuss his JACC: Heart Failure…
- Post-PCI Hematoma: What IVUS Tells Us | JACC Baran · 35 minPercutaneous coronary intervention (PCI) is safer than ever, yet coronary hematoma remains an underrecognized cause of early ischemic complications. In this episode, Host…
- Pediatric Heart Transplantation: When Priority Doesn't Match Urgency | JACC Baran · 35 minPediatric heart transplantation is one of medicine's scarcest resources, where every allocation decision can mean the difference between life and death. But does the current…
- PACs: Benign Bystanders or AF in Disguise? | JACC Baran · 36 minPremature atrial complexes (PACs) are among the most common arrhythmias encountered in daily practice and are often dismissed as benign. But are they truly harmless—or could some…
- Cancer VTE + DOAC: Who Will Bleed? | JACC Baran · 40 minPatients with active cancer face a difficult balance: preventing recurrent venous thromboembolism while avoiding major bleeding during anticoagulation. But which patients are…
- HFpEF Without Obesity: What Coronary Microcirculation Tells Us | JACC Baran · 38 minHost Mitsuaki Sawano, MD, welcomes Kai Nogami, MD (Mayo Clinic), to discuss his JACC Brief Report, "Higher Prevalence of Coronary Microvascular Dysfunction in Patients With HFpEF…
- What Autopsy Reveals About MINOCA and Sudden Cardiac Death | JACC Baran · 46 minHosts Mitsuaki Sawano, MD, Kentaro Ejiri, MD, Hiroyuki Sato, MD, and Shun Kosaka, MD welcome Dr. Kosuke Nakasuka, MD, PhD to discuss his JACC study, Sudden Cardiac Death Due to…
- Remnant Cholesterol: Small Name, Big ASCVD Risk | JACC Baran · 42 minHosts Mitsuaki Sawano, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD welcome Takahito Doi, MD, PhD to discuss his JACC Brief Report, “Risk of Atherosclerotic Cardiovascular…







